Market Research Logo

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany

Summary

Germany has a mature healthcare market based on its high healthcare expenditure and pharmaceutical production. The increasingly elderly population and its associated disease burden are expected to drive the growth of the pharmaceutical market, while government initiatives to reduce healthcare expenditure will limit growth.

The value of the German pharmaceuticals market increased from EUR37.3 Billion (US$54.7 Billion) in 2008 to EUR43.3 Billion (US$57.6 Billion) in 2013 at a Compound Annual Growth Rate (CAGR) of 1.0%. In US dollar terms, the market declined from US$54.7 Billion in 2008 to US$51.2 Billion in 2012 at a negative CAGR of 1.7% due to frequent currency devaluation. The value of the pharmaceuticals market is expected to reach US$65 Billion in 2020 from US$58.6 Billion in 2014, increasing at a CAGR of 1.7% (Federal Health Reporting, 2014c). Germany is the largest healthcare market among the EU member states.

The German medical device market was valued at US$18.9 Billion in 2008, which increased to US$23.8 Billion in 2013, and is expected to grow at a CAGR of 5.6% from US$24.8 Billion in 2014 to US$34.4 Billion in 2020. The main segments (cardiovascular devices, In Vitro Diagnostics (IVD) and orthopedics devices, wound care management, and hospital supplies) will drive market growth.

The market is driven by the following factors -

  • Increasing awareness regarding early disease detection and diagnosis.
  • Advances in medical technology.
  • Increasingly elderly population.
Germany has been witnessing consistent economic growth despite its significant contribution to the bailout of the EU states such as Greece, Ireland, Portugal and Cyprus. This is due largely to the existence of a strong political environment. The coalition government of Christian Democratic Union and the Christian Social Union led by the Chancellor Angela Merkel has been in power since 2005. This has enabled the government to fully implement its policies. Germany is the largest economy in Europe and has played a critical role in finding a solution to the eurozone debt crisis. The International Monetary Fund (IMF) forecasts that over the next five to seven years, GDP per capita will register a steady increase as a result of government efforts.

The report CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Germany, provides information on the healthcare, regulatory, and reimbursement landscape in Germany. In depth, it provides the following analysis -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Sanofi, Bayer, Roche and Pfizer) and profiles and SWOT analyses of the major players in the medical device market (Johnson & Johnson, Medtronic, Baxter International and B.Braun).
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices.
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
  • An overview of the opportunities for and challenges to growth in the German healthcare market.
Companies mentioned in this report: AstraZeneca, Pfizer, Teva, Eli Lilly, Novo Nordisk, Merck, Pfizer, Amgen, Otsuka, Merck, Sanofi-Aventis, Endo, Novartis, Schering-Plough, GSK, Schering-Plough, Novartis, Novartis.

Scope



The report provides information on the healthcare, regulatory, and reimbursement landscape in Germany, and includes -
  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Novartis, Sanofi, Bayer, Roche and Pfizer) and profiles and SWOT analyses of the major players in the medical device market (Johnson & Johnson, Medtronic, Baxter International and B.Braun)
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the German healthcare market
  • Reasons to buy

    This report will enhance your decision-making capability by allowing you to -
    • Develop business strategies by understanding the trends shaping and driving German healthcare market
    • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
    • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
    • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
    • Identify, understand, and capitalize on the opportunities and challenges in German healthcare market


    1 Table of Contents
    1.1 List of Tables
    1.2 List of Figures
    2 Executive Summary
    3 Introduction
    3.1 GlobalData Report Guidance
    4 Overview of the Pharmaceutical and Medical Device Markets
    4.1 Pharmaceutical Market
    4.1.1 Market Overview
    4.1.2 Pharmaceutical Imports and Exports
    4.1.3 Supply Channels
    4.1.4 Market Segments
    4.1.5 Overview of Top Five Disease Areas
    4.1.6 Major Players
    4.2 Medical Device Market
    4.2.1 Market Overview
    4.2.2 Overview of Top Five Segments
    4.2.3 Major Players
    4.3 Market Drivers and Barriers
    4.3.1 Drivers
    4.3.2 Barriers
    5 Market Access
    5.1 Reimbursement and Payer Landscape
    5.1.1 Overview of Healthcare System
    5.1.2 Reimbursement Process
    5.1.3 Overview of Insurance Providers
    5.1.4 Patient Share in Healthcare Spending
    5.1.5 Price Trend in Healthcare Services
    5.1.6 Pricing Policies
    5.2 Regulatory Landscape
    5.2.1 Overview of Regulatory Agencies
    5.2.2 Market Authorization Procedure for Pharmaceutical Products
    5.2.3 Market Authorization Procedure for Medical Devices
    5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing
    5.2.5 Licensing Process for Pharmaceutical Exports and Imports
    5.2.6 Intellectual Property Rights
    5.2.7 Clinical Trial Regulations
    5.2.8 Pharmaceutical Advertising Regulations
    5.2.9 Pharmacy Regulations
    5.2.10 Labeling and Packaging Regulations
    6 Country Analysis
    6.1 Political Environment
    6.1.1 Political Structure
    6.1.2 Analysis of the Current Political Environment
    6.1.3 Healthcare Policy Initiatives
    6.2 Economic Landscape
    6.3 Economic Indicators
    6.3.1 Gross Domestic Product
    6.3.2 Gross National Income
    6.3.3 Inflation
    6.3.4 Currency Exchange Rate
    6.3.5 Foreign Direct Investment
    6.3.6 Foreign Exchange Reserves
    6.3.7 Trade Balance
    6.3.8 General Government Structural Balance
    6.3.9 General Government Net Debt
    6.3.10 Major Industries
    6.4 Demographics
    6.4.1 Population
    6.4.2 Urban-Rural Share
    6.4.3 Distribution by Age Group
    6.4.4 Birth Rate
    6.4.5 Mortality
    6.4.6 Causes of Mortality
    6.4.7 Health Status by Gender and Age
    6.4.8 Education and Literacy
    6.4.9 Employment
    6.4.10 Disease Burden
    6.5 Healthcare Infrastructure
    6.5.1 Healthcare Facilities
    6.5.2 Healthcare Parameters
    6.5.3 Environmental Health
    6.5.4 Healthcare Personnel
    6.6 Healthcare Expenditure
    6.6.1 Overview
    6.6.2 Public-Private Sector Share
    6.6.3 Major Components of Healthcare Spending
    6.6.4 Spending in Science and Technology Research and Development
    6.7 Trade Associations
    6.7.1 The Association of Research Based Pharmaceutical Companies
    6.7.2 The Federation of Pharmaceutical Manufacture
    6.7.3 The Federation of Pharmaceutical Industry
    6.8 Trade Fairs
    7 Opportunities and Challenges
    7.1 Opportunities
    7.2 Challenges
    8 Appendix
    8.1 Abbreviations
    8.2 Bibliography
    8.3 Research Methodology
    8.3.1 Coverage
    8.3.2 Secondary Research
    8.3.3 Forecasts
    8.3.4 Expert Panel
    8.4 Contact Us
    8.5 Disclaimer
    1.1 List of Tables
    Table 1: Pharmaceutical Market, Germany, Revenue ($bn), 2009-2016
    Table 2: Pharmaceutical Market, Germany, Revenue Forecast ($bn), 2017-2021
    Table 3: Pharmaceutical Market, Germany, Pharmaceutical Imports and Exports ($bn), 2009-2015
    Table 4: Pharmaceutical Market, Germany, Wholesale Mark-up for Proprietary Medicinal Products ($bn), 2017
    Table 5: Pharmaceutical Market, Germany, Retail Pharmacy Mark-up for Proprietary Medicinal Products ($bn), 2017
    Table 6: Pharmaceutical Market, Germany, Generic Pharmaceutical Market Revenue ($bn), 2009-2016
    Table 7: Pharmaceutical Market, Germany, Biological Drugs in Pipeline and Approved, 2009-2015
    Table 8: Pharmaceutical Market, Germany, OTC Drug Market Revenue ($bn), 2009-2016
    Table 9: Pharmaceutical Market, Germany, Major OTC Drug Classes, Revenue ($m), 2015
    Table 10: Pharmaceutical Market, Germany, Major Disease Areas, Total Cost of Illness ($bn), 2008
    Table 11: Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016
    Table 12: Pharmaceutical Market, Novartis, Planned Filings, 2017-2020
    Table 13: Sanofi, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016
    Table 14: Pharmaceutical Market, Sanofi, Global, Late-stage Pipeline, 2017
    Table 15: Bayer, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2016
    Table 16: Pharmaceutical Market, Roche, Global, Revenue ($m) and Annual Growth (%) of Major Products, 2016
    Table 17: Pharmaceutical Market, Roche, Global, Late-stage Pipeline, 2017
    Table 18: Pharmaceutical Market, Pfizer, Global, Revenue ($m) and Annual Growth (%) of Major Products, 2016
    Table 19: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2017
    Table 20: Medical Device Market, Germany, Revenue ($bn), 2009-2016
    Table 21: Medical Device Market, Germany, Revenue Forecast ($bn), 2017-2021
    Table 22: Medical Device Market, Germany, Revenue by Segment ($bn), 2016
    Table 23: Ophthalmic Devices Market, Germany, Revenue ($bn), 2009-2016
    Table 24: Wound Care Management Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2012
    Table 25: Orthopedic Devices Market, Germany, Revenue ($bn), 2009-2016
    Table 26: Orthopedic Devices Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2016
    Table 27: Ophthalmic Devices Market, Germany, Revenue ($bn), 2009-2016
    Table 28: Ophthalmic Devices Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2015
    Table 29: Cardiovascular Devices Market, Germany, Revenue of Major Players ($bn), 2009-2016
    Table 30: Cardiovascular Devices Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2015
    Table 31: IVD Market, Germany, Revenue ($bn), 2009-2016
    Table 32: IVD Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2014
    Table 33: Medical Device Market, Germany, Revenue ($m) and Market Share (%) of Major Companies, 2012
    Table 34: Medical Device Market, Medtronic, Major Products, 2016
    Table 35: Baxter International, Global, Major Products, 2017
    Table 36: Market Access, Germany, Number of SHI Providers, 2009-2017
    Table 37: Market Access, Germany, Out-of-Pocket Expenditure (%), 2009-2015
    Table 38: Market Access, Germany, Healthcare Price Index, Annual Change (%), 2009-2016
    Table 39: Market Access, Germany, Early Assessment of Drugs, 2013
    Table 40: Market Access, Germany, Patent Application Fees, 2017
    Table 41: Market Access, Germany, Trademark Registration Fees, 2017
    Table 42: Market Access, Germany, Voluntary Harmonization Procedure, 2017
    Table 43: Economic Indicators, Germany, Gross Domestic Product per Capita ($), 2009-2016
    Table 44: Economic Indicators, Germany, Gross Domestic Product per Capita Forecast ($), 2017-2021
    Table 45: Economic Indicators, Germany, Gross Domestic Product Annual Growth (%), 2009-2016
    Table 46: Economic Indicators, Germany, Gross Domestic Product Annual Growth Forecast (%), 2017-2021
    Table 47: Economic Indicators, Germany, Gross National Income per Capita ($), 2009-2016
    Table 48: Economic Indicators, Germany, Average Consumer Price Index, 2009-2016
    Table 49: Economic Indicators, Germany, Average Consumer Price Annual Change (%), 2009-2016
    Table 50: Economic Indicators, Germany, Currency Exchange Rate (€ per $), 2009-2016
    Table 51: Economic Indicators, Germany, Foreign Direct Investment ($bn), 2009-2015
    Table 52: Economic Indicators, Germany, Foreign Exchange Reserves ($bn), 2009-2016
    Table 53: Economic Indicators, Germany, Imports of Goods and Services ($bn), 2009-2016
    Table 54: Economic Indicators, Germany, Exports of Goods and Services ($bn), 2009-2016
    Table 55: Economic Indicators, Germany, Government Structural Balance ($bn), 2009-2016
    Table 56: Economic Indicators, Germany, General Government Net Debt ($bn), 2009-2016
    Table 57: Economic Indicators, Germany, Major Industries by Revenue ($bn), 2015
    Table 58: Demographics, Germany, Population (million), 2009-2016
    Table 59: Demographics, Germany, Population (million), 2017-2021
    Table 60: Demographics, Germany, Urban-Rural Population Share (%), 2009-2016
    Table 61: Demographics, Germany, Population Distribution by Age Group (%), 2009-2016
    Table 62: Demographics, Germany, Population Distribution by Age Group Forecast (%), 2017-2021
    Table 63: Demographics, Germany, Births (per 1,000 population), 2009-2016
    Table 64: Demographics, Germany, Mortality (per 1,000 population), 2009-2016
    Table 65: Economic Indicators, Germany, Major Causes of Mortality, 2015
    Table 66: Demographics, Germany, Infant Mortality (per 1,000 live births), 2009-2016
    Table 67: Demographics, Germany, Immunization Rate (%), 2009-2016
    Table 68: Demographics, Germany, Major Causes of Male Mortality, 2015
    Table 69: Demographics, Germany, Major Causes of Female Mortality, 2015
    Table 70: Demographics, Germany, Gender Ratio (M/F), 2009-2016
    Table 71: Demographics, Germany, Life Expectancy at Birth (years), 2009-2016
    Table 72: Demographics, Germany, Highest Level of General Education Completed, Share (%), 2015
    Table 73: Demographics, Germany, Vocational Qualification, Share (%), 2015
    Table 74: Demographics, Germany, Unemployment Rate (%), 2009-2016
    Table 75: Demographics, Germany, Most Frequently Diagnosed Diseases (‘000), 2015
    Table 76: Demographics, Germany, Disability-Adjusted Life Years by Major Disease (‘000), 2012
    Table 77: Healthcare Infrastructure, Germany, Number of Hospitals, 2009-2015
    Table 78: Healthcare Infrastructure, Germany, Acute Care Hospitals (per 10,000 population), 2009-2015
    Table 79: Healthcare Infrastructure, Germany, Diagnostic Equipment (per million population), 2009-2015
    Table 80: Healthcare Infrastructure, Germany, Hospital Beds (per 1,000 population), 2009-2015
    Table 81: Healthcare Infrastructure, Germany, Acute Care Hospital Beds (per 1,000 population), 2009-2015
    Table 82: Healthcare Infrastructure, Germany, Psychiatric Hospital Beds (per 1,000 population), 2009-2015
    Table 83: Healthcare Infrastructure, Germany, PM2.5 (µg per mP3P), 2009-2015
    Table 84: Healthcare Infrastructure, Germany, CO2 Emissions (million metric tons), 2009-2015
    Table 85: Healthcare Infrastructure, Germany, Healthcare Personnel (‘000), 2009-2015
    Table 86: Healthcare Infrastructure, Germany, Doctors (per 1,000 population), 2009-2015
    Table 87: Healthcare Infrastructure, Germany, Dentists (per 1,000 population), 2009-2015
    Table 88: Healthcare Infrastructure, Germany, Pharmacists (per 1,000 population), 2009-2015
    Table 89: Healthcare Infrastructure, Germany, Nurses (per 1,000 population), 2009-2015
    Table 90: Healthcare Expenditure, Germany, Healthcare Expenditure as Percentage of GDP (%), 2009-2015
    Table 91: Healthcare Expenditure, Germany, Public-Private Share (%), 2009-2015
    Table 92: Healthcare Expenditure, Germany, Public-Private Share (%), 2015
    Table 93: Healthcare Expenditure, Germany, R&D Expenditure as Percentage of GDP (%), 2009-2015
    Table 94: Healthcare Expenditure, Germany, Major Healthcare Trade Fairs, 2017
    1.2 List of Figures
    Figure 1: Pharmaceutical Market, Germany, Revenue ($bn), 2009-2021
    Figure 2: Medical Device Market, Germany, Revenue ($bn), 2009-2021
    Figure 3: Country Profile, Germany, 2016
    Figure 4: Pharmaceutical Market, Germany, Revenue ($bn), 2009-2016
    Figure 5: Pharmaceutical Market, Germany, Revenue Forecast ($bn), 2017-2021
    Figure 6: Pharmaceutical Market, Germany, Pharmaceutical Imports and Exports ($bn), 2009-2015
    Figure 7: Pharmaceutical Market, Germany, Supply Channel, 2017
    Figure 8: Pharmaceutical Market, Germany, Generic Pharmaceutical Market Revenue ($bn), 2008-2016
    Figure 9: Pharmaceutical Market, Germany, Biological Drugs in Pipeline and Approved, 2009-2015
    Figure 10: Pharmaceutical Market, Germany, OTC Drug Market Revenue ($bn), 2009-2016
    Figure 11: Pharmaceutical Market, Germany, Major OTC Drug Classes, Revenue ($m), 2015
    Figure 12: Pharmaceutical Market, Germany, Major Disease Areas, Total Cost of Illness ($bn), 2008
    Figure 13: Medical Device Market, Germany, Revenue ($bn), 2009-2016
    Figure 14: Medical Device Market, Germany, Revenue Forecast ($bn), 2017-2021
    Figure 15: Medical Device Market, Germany, Revenue by Segment ($bn), 2016
    Figure 16: Wound Care Management Market, Germany, Revenue ($bn), 2009-2016
    Figure 17: Wound Care Management Market, Germany, Market Share of Major Players (%), 2012
    Figure 18: Orthopedic Devices Market, Germany, Revenue ($bn), 2009-2016
    Figure 19: Orthopedic Devices Market, Germany, Market Share of Major Players (%), 2016
    Figure 20: Ophthalmic Devices Market, Germany, Revenue ($bn), 2009-2016
    Figure 21: Ophthalmic Devices Market, Germany, Market Share of Major Players (%), 2015
    Figure 22: Cardiovascular Devices Market, Germany, Revenue ($bn), 2009-2016
    Figure 23: Cardiovascular Devices Market, Germany, Market Share of Major Players (%), 2015
    Figure 24: IVD Market, Germany, Revenue ($bn), 2009-2016
    Figure 25: IVD Market, Germany, Market Share of Major Companies (%), 2014
    Figure 26: Medical Device Market, Germany, Revenue of Major Companies ($m), 2012
    Figure 27: Healthcare Market, Germany, Drivers and Barriers, 2017
    Figure 28: Market Access, Germany, Roles of Regulatory Bodies, 2017
    Figure 29: Market Access, Germany, Reimbursement Process, 2017
    Figure 30: Market Access, Germany, Number of SHI Providers, 2009-2017
    Figure 31: Market Access, Germany, Out-of-Pocket Expenditure (%), 2009-2015
    Figure 32: Market Access, Germany, Healthcare Price Index, Annual Change (%), 2009-2016
    Figure 33: Market Access, Germany, AMNOG Reimbursement Process for Drugs, 2017
    Figure 34: Market Access, Germany, Organizational Structure of BfArM, 2017
    Figure 35: Market Access, Germany, Organizational Structure of PEI, 2017
    Figure 36: Market Access, EU, Centralized Procedure, Market Authorization, Pre-submission Phase, 2017
    Figure 37: Market Access, EU, Centralized Procedure, Market Authorization, Pre-opinion Phase, 2017
    Figure 38: Market Access, EU, Centralized Procedure, Market Authorization, Post-opinion Phase, 2017
    Figure 39: Market Access, EU, Decentralized Procedure, Market Authorization, 2017
    Figure 40: Market Access, EU, Conformity Assessment of Class I Medical Devices, 2017
    Figure 41: Market Access, EU, Conformity Assessment of Class IIa Medical Devices, 2017
    Figure 42: Market Access, EU, Conformity Assessment of Class IIb Medical Devices, 2017
    Figure 43: Market Access, EU, Conformity Assessment of Class III Medical Devices, 2017
    Figure 44: Market Access, Germany, Patent Approval Process, 2017
    Figure 45: Market Access, Germany, Trademark Approval Process, 2017
    Figure 46: Economic Indicators, Germany, Gross Domestic Product per Capita ($), 2009-2016
    Figure 47: Economic Indicators, Germany, Gross Domestic Product per Capita Forecast ($), 2017-2021
    Figure 48: Economic Indicators, Germany, Gross Domestic Product Annual Growth (%), 2009-2016
    Figure 49: Economic Indicators, Germany, Gross Domestic Product Annual Growth Forecast (%), 2017-2021
    Figure 50: Economic Indicators, Germany, Gross National Income per Capita ($), 2009-2016
    Figure 51: Economic Indicators, Germany, Average Consumer Price Index, 2009-2016
    Figure 52: Economic Indicators, Germany, Average Consumer Price Annual Change (%), 2009-2016
    Figure 53: Economic Indicators, Germany, Currency Exchange Rate (€ per $), 2009-2016
    Figure 54: Economic Indicators, Germany, Foreign Direct Investment ($bn), 2009-2015
    Figure 55: Economic Indicators, Germany, Foreign Exchange Reserves ($bn), 2009-2016
    Figure 56: Economic Indicators, Germany, Imports of Goods and Services ($bn), 2009-2016
    Figure 57: Economic Indicators, Germany, Exports of Goods and Services ($bn), 2009-2016
    Figure 58: Economic Indicators, Germany, Government Structural Balance ($bn), 2009-2016
    Figure 59: Economic Indicators, Germany, General Government Net Debt ($bn), 2009-2016
    Figure 60: Economic Indicators, Germany, Major Industries by Revenue ($bn), 2015
    Figure 61: Demographics, Germany, Population (million), 2009-2016
    Figure 62: Demographics, Germany, Population (million), 2017-2021
    Figure 63: Demographics, Germany, Urban-Rural Population Share (%), 2009-2016
    Figure 64: Demographics, Germany, Population Distribution by Age Group (%), 2009-2016
    Figure 65: Demographics, Germany, Population Distribution by Age Group Forecast (%), 2017-2021
    Figure 66: Demographics, Germany, Births (per 1,000 population), 2009-2016
    Figure 67: Demographics, Germany, Mortality (per 1,000 population), 2009-2016
    Figure 68: Demographics, Germany, Major Causes of Mortality, 2015
    Figure 69: Demographics, Germany, Infant Mortality (per 1,000 live births), 2009-2016
    Figure 70: Demographics, Germany, Immunization Rate (%), 2009-2016
    Figure 71: Demographics, Germany, Major Causes of Male Mortality, 2015
    Figure 72: Demographics, Germany, Major Causes of Female Mortality, 2015
    Figure 73: Demographics, Germany, Gender Ratio (M/F), 2009-2016
    Figure 74: Demographics, Germany, Life Expectancy at Birth (years), 2009-2016
    Figure 75: Demographics, Germany, Highest Level of General Education Completed, Share (%), 2015
    Figure 76: Demographics, Germany, Vocational Qualification, Share (%), 2015
    Figure 77: Demographics, Germany, Unemployment Rate (%), 2009-2016
    Figure 78: Demographics, Germany, Most Frequently Diagnosed Diseases (‘000), 2015
    Figure 79: Demographics, Germany, Disability-Adjusted Life Years by Major Disease (‘000), 2012
    Figure 80: Healthcare Infrastructure, Germany, Number of Hospitals, 2009-2015
    Figure 81: Healthcare Infrastructure, Germany, Acute Care Hospitals (per 10,000 population), 2009-2015
    Figure 82: Healthcare Infrastructure, Germany, Diagnostic Equipment (per million population), 2009-2015
    Figure 83: Healthcare Infrastructure, Germany, Hospital Beds (per 1,000 population), 2009-2015
    Figure 84: Healthcare Infrastructure, Germany, Acute Care Hospital Beds (per 1,000 population), 2009-2015
    Figure 85: Healthcare Infrastructure, Germany, Psychiatric Hospital Beds (per 1,000 population), 2009-2015
    Figure 86: Healthcare Infrastructure, Germany, PM2.5 (µg per mP3P), 2009-2015
    Figure 87: Healthcare Infrastructure, Germany, CO2 Emissions (million metric tons), 2009-2015
    Figure 88: Healthcare Infrastructure, Germany, Healthcare Personnel (‘000), 2009-2015
    Figure 89: Healthcare Infrastructure, Germany, Physicians (per 1,000 population), 2009-2015
    Figure 90: Healthcare Infrastructure, Germany, Dentists (per 1,000 population), 2009-2015
    Figure 91: Healthcare Infrastructure, Germany, Pharmacists (per 1,000 population), 2009-2015
    Figure 92: Healthcare Infrastructure, Germany, Nurses (per 1,000 population), 2009-2015
    Figure 93: Healthcare Expenditure, Germany, Healthcare Expenditure as Percentage of GDP (%), 2009-2015
    Figure 94: Healthcare Expenditure, Germany, Public-Private Share (%), 2009-2015
    Figure 95: Healthcare Expenditure, Germany, Public-Private Share (%), 2015
    Figure 96: Healthcare Expenditure, Germany, R&D Expenditure as Percentage of GDP (%), 2009-2015
    Figure 97: Healthcare Market, Germany, Opportunities and Challenges, 2017

    Download our eBook: How to Succeed Using Market Research

    Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

    Download eBook

    Share this report